Anesthesia Recovery Clinical Trial
Official title:
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB.
The investigators' aim is to prove that half dose sugammadex in combination with neostigmine 0.05 mg/kg is non-inferior to the recommended dose of sugammadex for the reversal of deep ( absence of Trian of Four response :TOF) or moderate ( TOF 1 or 2 twiches) muscle paralysis in patients undergoing surgery under general anesthesia. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02141412 -
Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia
|
Phase 4 | |
Completed |
NCT03553082 -
Airway Complications After LMA in Children
|
N/A | |
Recruiting |
NCT03200964 -
OS Anesthesia Followup of All Bariatric Procedures at One Hospital
|
||
Recruiting |
NCT06334939 -
Bispectral Index, Suppression Rate and Emergence Agitation in Spine Surgeries
|